Editor’s Favorite: Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses​. Sheikhbahaei and colleagues prospectively apply 99mTc-MIBI SPECT/CT to interrogate clinical stage T1 renal masses in 48 patients. Surgical pathology confirmed benign diagnosis (oncocytoma/hybrid oncocytic-chromophobe tumors) in 7 and chromophobe renal cell carcinoma (behave as indolent) in 2. 99mTc-MIBI SPECT/CT improves the characterization of benign renal masses.

Current Issue


Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses

Sheikhbahaei, Sara; Jones, Christopher S.; Porter, Kristin K.; More

Clinical Nuclear Medicine . 42(4):e188-e193, April 2017.





1 2 3 4 5